Molecular Detection of Circulating Tumor Cells in the Peripheral Blood of Patients with Colorectal Cancer Using RT-PCR: Significance of the Prediction of Postoperative Metastasis
- 440 Downloads
- 65 Citations
Abstract
Background
Approximately 20%–45% of colorectal cancer (CRC) patients ultimately develop local recurrence or metastasis following curative surgical resection. The latter is caused by tumor cells shed from the primary carcinoma prior to or during operation, currently undetected by standard clinical staging. Fortunately, the presence of tumor cells in peripheral blood can be detected by molecular methods and is being regarded increasingly as a clinically relevant prognostic factor.
Materials and Methods
To detect the presence of circulating tumor cells and evaluate their relationship to postoperative metastatic relapse, we simultaneously examined human telomerase reverse transcriptase (hTERT), cytokeratin-19 (CK-19), cytokeratin-20 (CK-20), and carcinoembryonic antigen (CEA) mRNA (messenger RNA) in the peripheral blood of 72 CRC patients and 30 healthy individuals. Using a reverse-transcriptase polymerase chain reaction (RT-PCR), these tumor-related mRNAs were amplified; in addition, analyses were carried out for their correlation with patients’ clinicopathologic features, as well as the occurrence of postoperative metastasis.
Results
In RT-PCR analysis of the peripheral blood, 69.4% (50 out of 72), 66.7% (48 out of 72), 52.8% (38 out of 72), and 72.2% (52 out of 72) of CRC patients were positive for hTERT, CK-19, CK-20, and CEA mRNA respectively. All 30 healthy individuals were negative for hTERT and CEA mRNA expression, while 2 were positive for either CK-19 mRNA or CK-20 mRNA expression. The detection of CEA mRNA was significantly correlated with depth of tumor invasion (P = 0.012), vessel invasion (P = 0.035), TNM stage (P < 0.0001), and postoperative metastasis (P < 0.0001), while positive hTERT mRNA was correlated with TNM stage (P = 0.037) and CK-19 was correlated with depth of tumor invasion (P = 0.039) and postoperative metastasis (P = 0.017). In addition, multivariate logistic regression showed that only CEA mRNA was an independent and significant predictor of postoperative metastasis (P = 0.006). Our findings suggest that CEA mRNA may be a more reliable marker than hTERT, CK-19, and CK-20 for the detection of circulating cancer cells in the peripheral blood of CRC patients.
Conclusions
Using RT-PCR for the detection of CEA mRNA is feasible and may be a promising tool for early detection of micrometastatic circulating tumor cells in CRC patients. CRC patients expressing positive CEA mRNA in peripheral blood have a significantly higher risk of postoperative metastasis. Nevertheless, confirmation of CEA mRNA as a prognostic predictive factor requires the continuation of patient follow-up.
Keywords
Circulate Tumor Cell hTERT mRNA mRNA Marker Circulate Cancer Cell Postoperative MetastasisReferences
- 1.Fidler IJ, Ellis LM. The implication of angiogenesis for the biology and therapy of cancer metastases. Cell 1994;79:185–188PubMedCrossRefGoogle Scholar
- 2.Moertel CG. Chemotherapy for colorectal cancer. N Engl J Med 1994;330:1136–1142PubMedCrossRefGoogle Scholar
- 3.Kune GA, Kune S, Field B, et al. Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne colorectal cancer study. Dis Col Rectum 1990;33:938–946CrossRefGoogle Scholar
- 4.Ghossein RA, Bhattacharya S. Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours. Eur J Cancer 2000;36:1681–1694PubMedCrossRefGoogle Scholar
- 5.Ghossein RA, Bhattacharya S, Rosai J. Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res 1999;5:1950–1960PubMedGoogle Scholar
- 6.Smith B, Selby P, Southgate J, et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227–1229PubMedCrossRefGoogle Scholar
- 7.Burchill SA, Lewis IJ, Selby P. Improved methods using the reverse transcriptase-polymerase chain reaction to detect tumor cells. Br J Cancer 1999;79:971–977PubMedCrossRefGoogle Scholar
- 8.Guadagni F, Kantor J, Aloe S, et al. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Cancer Res 2001;61:2523–2532PubMedGoogle Scholar
- 9.Ito S, Nakanishi H, Hirai T, et al. Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler. Cancer Lett 2002;183:195–203PubMedCrossRefGoogle Scholar
- 10.Lledo SM, Garcia-Granero E, Dasi F, et al. Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer. Colorectal Dis 2004;6:236–242PubMedCrossRefGoogle Scholar
- 11.Castells A, Boix L, Bessa X, et al. Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction. Br J Cancer 1998;78:1368–1372PubMedGoogle Scholar
- 12.Wharton RQ, Jonas SK, Glover C, et al. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Clin Cancer Res 1999;5:4158–4163PubMedGoogle Scholar
- 13.Wong IH, Yeo W, Chan AT, et al. Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes’ stage, serum carcinoembryonic antigen level and tumor progression. Cancer Lett 2001;162:65–73PubMedCrossRefGoogle Scholar
- 14.Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging handbook. Berlin Heidelberg New York, Springer, 2001:131–133Google Scholar
- 15.Yamaguchi K, Takagi Y, Aoki S, et al. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 2000;232:58–65PubMedCrossRefGoogle Scholar
- 16.Burchill SA, Bradbury MF, Pittman K, et al. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995;71:278–281PubMedGoogle Scholar
- 17.Mori M, Mimori K, Ueo H, et al. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer 1996;68:739–743PubMedCrossRefGoogle Scholar
- 18.Soeth E, Roder C, Juhl H, et al. The detection of disseminated tumor cells in bone marrow from colorectal cancer patients by a cytokeratin-20-specific nested reverse transcriptase-polymerase chain reaction is related to the stage of disease. Int J Cancer 1996;69:278–282PubMedCrossRefGoogle Scholar
- 19.O’Sullivan GC, Collins JK, Kelly J, et al. Micrometastases: marker of metastatic potential or evidence of residual disease? Gut 1997;40:512–515PubMedGoogle Scholar
- 20.Sadahiro S, Suzuki T, Tokunaga N, et al. Detection of tumor cells in the portal and peripheral blood of patients with colorectal carcinoma using competitive reverse transcriptase-polymerase chain reaction. Cancer 2001;92:1251–1258PubMedCrossRefGoogle Scholar
- 21.Wyld DK, Selby P, Perren TJ, et al. Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer 1998;79:288–293PubMedCrossRefGoogle Scholar
- 22.Ruud P, Fodstad O, Hovig E. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells. Int J Cancer 1999;80:119–125PubMedCrossRefGoogle Scholar
- 23.Vlems FA, Diepstra JH, Cornelissen IM, et al. Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue. Mol Pathol 2002;55:156–163PubMedCrossRefGoogle Scholar
- 24.Conzelmann M, Linnemann U, Berger MR. Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use? Int J Colorectal Dis 2005;20:137–146PubMedCrossRefGoogle Scholar